- Investing Ideas
- South Korean Healthcare Undervalued based on future growth
South Korean Healthcare Undervalued based on future growth
Results
7
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
7 companies
T&L
Market Cap: ₩490.6b
Engages in the manufacture and sale of medical and polymer material products in South Korea.
A340570
₩61,200.00
7D
-0.5%
1Y
-14.9%
InBodyLtd
Market Cap: ₩393.5b
Provides body composition analysis solutions worldwide.
A041830
₩29,500.00
7D
0.5%
1Y
21.9%
Value Added Technology
Market Cap: ₩341.6b
Manufactures and sells dental medical X-ray devices in Korea, Asia, Australia, Europe, North and South America, and the Middle East.
A043150
₩23,000.00
7D
-0.4%
1Y
13.3%
Dentium
Market Cap: ₩329.3b
Manufactures and sells dental medical instrument worldwide.
A145720
₩53,300.00
7D
0.6%
1Y
-27.0%
Interojo
Market Cap: ₩245.4b
Manufactures and sells contact lenses in South Korea and internationally.
A119610
₩21,500.00
7D
4.1%
1Y
n/a
Vieworks
Market Cap: ₩233.0b
Develops, manufactures, and sells imaging systems and solutions.
A100120
₩27,150.00
7D
-2.2%
1Y
10.6%
Meta Biomed
Market Cap: ₩115.5b
Engages in the research, development, and production of dental and surgical materials in South Korea, Asia, Europe, the United States, and Africa.
A059210
₩4,420.00
7D
-3.1%
1Y
-3.9%